Beijing Beilu Pharmaceutical Co.,Ltd. Posted 4.6 Million Yuan Net Loss in 2022

Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陆药业股份有限公司) (300016.SZ) reported a net loss of 4.6 million yuan in 2022, reversing a net profit of 110.3 million yuan for the previous year.

Meanwhile, the company posted 765.9 million yuan in revenue, down 10.9% year-on-year.

At the end of the reporting period, it had 2.8 billion yuan in total assets and 892.3 million yuan in total liabilities, with a liability-to-asset ratio of 31.7%.